AD Immunotherapy : Towards a disease modification therapy in Alzheimer disease via targeting Tau protein with monoclonal antibodies

Principal Investigators

JANSSEN PHARMACEUTICA

Institution

JANSSEN PHARMACEUTICA

Contact information of lead PI

Country

Belgium

Title of project or programme

AD Immunotherapy : Towards a disease modification therapy in Alzheimer disease via targeting Tau protein with monoclonal antibodies

Source of funding information

Flanders Innovation & Entrepreneurship

Total sum awarded (Euro)

284,943

Start date of award

01/05/2016

Total duration of award in years

Keywords

Research Abstract

Further information available at:

Types: Investments < €500k

Member States: Belgium

Diseases: N/A

Years: 2016

Database Categories: N/A

Database Tags: N/A